» Authors » Eric Thervet

Eric Thervet

Explore the profile of Eric Thervet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 218
Citations 3234
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertrand D, Chavarot N, Olagne J, Greze C, Gatault P, Danthu C, et al.
Transpl Int . 2024 Dec; 37:13544. PMID: 39712083
After kidney transplantation, conversion to belatacept is a promising alternative in patients with poor graft function or intolerance to calcineurin inhibitors. The risk of acute rejection has not been well...
2.
Caillard S, Meyer N, Solis M, Bertrand D, Jaureguy M, Anglicheau D, et al.
Kidney Int . 2024 Nov; 107(2):338-347. PMID: 39490986
The MTOR inhibitors have demonstrated antiviral properties, and prior non-randomized studies have suggested they may have a suppressive effect on BKPyV replication. Here, in this randomized, multicenter, controlled trial (BKEVER...
3.
Tardieu L, Anglicheau D, Sberro-Soussan R, Lemoine M, Golbin L, Fourdinier O, et al.
Clin Transplant . 2024 Aug; 38(8):e15424. PMID: 39136236
Background: Epstein-Barr virus (EBV) is a herpesvirus linked to nine different human tumors and lymphoproliferative disorders. Immunosuppression promotes EBV-driven malignancies. The most frequent EBV-induced malignancies are lymphomas and nasopharyngeal carcinoma....
4.
Meuleman M, Petitprez F, Pickering M, le Quintrec M, Artero M, DuVal A, et al.
J Am Soc Nephrol . 2024 May; 35(8):1034-1044. PMID: 38709564
No abstract available.
5.
Isnard P, Huynh T, Lhermitte L, Hermine O, Thervet E, Molina T
Kidney Int Rep . 2024 Mar; 9(3):725-729. PMID: 38481497
No abstract available.
6.
Lafont E, Blez D, Bildan M, Veyer D, Pere H, Puech J, et al.
Clin Infect Dis . 2023 Dec; 79(3):798-800. PMID: 38159041
No abstract available.
7.
Lazareth H, Thervet E
Kidney Res Clin Pract . 2023 Dec; 42(6):762-763. PMID: 38052520
No abstract available.
8.
Michon-Colin A, Metzger M, Bankir L, Gauci C, Brunel M, Baron S, et al.
Clin Kidney J . 2023 Dec; 16(12):2472-2481. PMID: 38046034
Background: Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to...
9.
Korb-Savoldelli V, Tran Y, Perrin G, Touchard J, Pastre J, Borowik A, et al.
J Med Internet Res . 2023 Oct; 25:e42384. PMID: 37843891
Background: Medication adherence plays a critical role in controlling the evolution of chronic disease, as low medication adherence may lead to worse health outcomes, higher mortality, and morbidity. Assessment of...
10.
Schwarz C, Georgin-Lavialle S, Lombardi Y, Marion O, Jambon F, Legendre C, et al.
Am J Kidney Dis . 2023 Sep; 83(3):329-339. PMID: 37741608
Rationale & Objective: Outcomes of kidney transplantation for patients with renal AA amyloidosis are uncertain, with reports of poor survival and high rates of disease recurrence. However, the data are...